PriMatrix for the Management of Diabetic Foot Ulcers
Public ClinicalTrials.gov record NCT03010319. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Prospective, Multi-center, Randomized, Controlled Trial Evaluating the Use of PriMatrix Dermal Repair Scaffold for the Management of Diabetic Foot Ulcers
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study will evaluate the efficacy of PriMatrix Dermal Repair Scaffold in the management of diabetic foot ulcers in subjects with diabetes mellitus versus the Standard of Care treatment. Half of patients will be treated using PriMatrix while the other half will receive Standard of Care treatment.
Study identification
- NCT ID
- NCT03010319
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 226 participants
Conditions and interventions
Conditions
Interventions
- PriMatrix Dermal Repair Scaffold Device
- Secondary Dressings Device
- Offloading device Device
Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2016
- Primary completion
- Jul 31, 2020
- Completion
- Jul 31, 2020
- Last update posted
- Apr 28, 2022
2017 – 2020
United States locations
- U.S. sites
- 17
- U.S. states
- 9
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| ILD Research Center | Carlsbad | California | 92009 | — |
| LA Foot & Ankle Clinic | Los Angeles | California | 90057 | — |
| Center for Clinical Research, Inc. | San Francisco | California | 94115 | — |
| Central Valley Vein and Wound | Selma | California | 93662 | — |
| Georgetown University | Washington D.C. | District of Columbia | 20057 | — |
| Barry University Clinical Research | North Miami | Florida | 33169 | — |
| LA Podiatry Group | West Palm Beach | Florida | 33406 | — |
| Podiatry 1st | Belleville | Illinois | 62226 | — |
| The Mount Sinai Medical Center | New York | New York | 10029 | — |
| Wound Care of Tulsa | Tulsa | Oklahoma | 74146 | — |
| Martin Foot and Ankle | York | Pennsylvania | 17402 | — |
| Podiatric Medical Partners of Texas, P.A. | Dallas | Texas | 75208 | — |
| UT Southwestern Medical Center | Dallas | Texas | 75390 | — |
| JPS Health Network | Fort Worth | Texas | 76104 | — |
| Futuro Clinical Trials | McAllen | Texas | 78501 | — |
| Element Research Group | San Antonio | Texas | 78229 | — |
| Foot and Ankle Institute | St. George | Utah | 84770 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03010319, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 28, 2022 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03010319 live on ClinicalTrials.gov.